SLC23A2 and colorectal cancer: Collectively, our finding indicates that VPA enhanced the synergistic anticancer effects of AA by upregulating SVCT2 expression in low-SVCT2-expressing colorectal cancer cells, suppressing the hormetic dose-response of AA.